Страна: Канада
Език: френски
Източник: Health Canada
Phosphate sodique de prednisolone
BAUSCH & LOMB INC
S01BA04
PREDNISOLONE
0.5%
Gouttes
Phosphate sodique de prednisolone 0.5%
Ophtalmique
15G/50G
Prescription
CORTICOSTEROIDS
Numéro de groupe d'ingrédients actifs (GIA) :0106288003; AHFS:
APPROUVÉ
2020-12-01
_ _ ENGLISH FRENCH PR MINIMS ® PREDNISOLONE SODIUM PHOSPHATE Prednisolone Sodium Phosphate Ophthalmic Solution, USP CORTICOSTEROID PRESCRIBING INFORMATION PRESENTATION Single dose clear, colorless, sterile eye drops, available as 0.5% w/v solution. Contains no preservative. ACTION MINIMS PREDNISOLONE SODIUM PHOSPHATE exerts its effect on the anterior segment of the eye by inhibition of inflammatory response to inciting agents of mechanical, chemical or immunological nature. INDICATIONS Single use of MINIMS PREDNISOLONE SODIUM PHOSPHATE is indicated in the following noninfectious inflammatory allergic conditions: allergic, non-purulent catarrhal, and vernal conjunctivitis; acute iritis; catarrhal corneal ulcer, cornea injuries; non-purulent blepharitis; nonspecific superficial keratitis; non-purulent phlyctenular kerato-conjunctivitis. During the course of therapy, if the inflammatory reaction does not respond within a reasonable period, institute other forms of therapy. CONTRANDICATIONS • Viral disease of the cornea and conjunctiva; tuberculosis of the eye; fungal disease of the eye; acute purulent untreated infections of the eye, which like other diseases caused by micro- organisms, may be masked or enhanced by the presence of the steroid. • Herpes simplex, varicella and vaccinia. • Hypersensitivity to any of the components of the medication. WARNINGS The use of corticosteroid ophthalmic drops during pregnancy or in infants should be avoided. PRECAUTIONS Fungal infection must be suspected in any persistent corneal ulceration where a steroid has been used or is in use. Increased intraocular pressure may develop following extended ophthalmic use of corticosteroid. Since increased intraocular pressure can lead to loss of vision, ophthalmic administration should be used only under adequate tonometric supervision in patients known to have glaucoma or have family history of glaucoma. As with adrenal corticosteroids, prednisolone sodium phosphate may mask, activate or enhance infection. If there is a possibility Прочетете целия документ